Author:
Garcia Tanya P.,Marder Karen
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Neuroscience
Reference29 articles.
1. Keogh R, Frost C, Owen G, Daniel RM, Langbehn DR, Leavitt B, et al. Medication use in early-HD participants in TRACK-HD: An investigation of its effects on clinical performance. PLoS Curr. 2016;8:1.
2. • Paulsen JS, Long JD, Johnson HJ, Aylward EH, Ross C, Williams JK, et al. Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study. Front Aging Neurosci. 2014;6:78. Provides examples of longitudinal study issues and analyses of current neurodegenerative disease study.
3. Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, et al. Clinical-genetic associations in the prospective huntington at risk observational study (PHAROS). JAMA Neurol. 2015;14620:1.
4. Tan X, Shiyko MP, Li R, Li Y, Dierker L. A time-varying effect model for intensive longitudinal data. Psychol Methods. 2012;17(1):61–77.
5. Zeger SL, Liang KY. An overview of methods for the analysis of longitudinal data. Stat Med. 1992;11(14–15):1825–39.
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献